|
Alexander, P. Foetal “Antigens in Cancer. Nature 235 (1972). 2Marilyn Monk, a. C. H. Human embryonic genes re-expressed in cancer cells. Oncogene 20, 8085-8091 (2001). 3Schöne, G. Untersuchungen über Karzinomimmunität bei Mäusen. Münchener Medizinische Wochenschrift 51, 2517-2519 (1906). 4G. I. Abelev, S. D. P., N. I. Khramkova, Z. A. Postnikova and I. S. Irlin. Production of Embryonal α-Globulin by Transplantable Mouse Hepatomas. Transplantation 1, 174–180 (1963). 5IuS, T. Detection of embryo-specific alpha-globulin in the blood serum of a patient with primary liver cancer. Vopr Med Khim 10, 90-91 (1964). 6Cornejo, K., Shi, M. & Jiang, Z. Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma. Human pathology 43, 1567-1572 (2012). 7Yong, K. J. et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. The New England journal of medicine 368, 2266-2276, doi:10.1056/NEJMoa1300297 (2013). 8Capurro, M. et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125, 89-97 (2003). 9Ashworth, T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14, 146-149 (1869). 10Fidler, I. J. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. NATURE REVIEWS 3, 1-6 (2003). 11Christine, Chaffer, L. & Weinberg, R. A. A Perspective on Cancer Cell Metastasis. Science 331 (2011). 12Alix-Panabieres, C. & Pantel, K. Circulating tumor cells: liquid biopsy of cancer. Clinical chemistry 59, 110-118 (2013). 13Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001). 14Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976). 15Campbell, L. L. & Polyak, K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell cycle 6, 2332-2338 (2007). 16Visvader, J. E. & Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature reviews. Cancer 8, 755-768, doi:10.1038/nrc2499 (2008). 17Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer research 69, 1302-1313 (2009). 18Fang, D. et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer research 65, 9328-9337 (2005). 19Chiba, T. et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties. Hepatology 44, 240-251 (2006). 20Singh, A. & Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741-4751 (2010). 1Alexander, P. Foetal “Antigens in Cancer. Nature 235 (1972). 2Marilyn Monk, a. C. H. Human embryonic genes re-expressed in cancer cells. Oncogene 20, 8085-8091 (2001). 3Schöne, G. Untersuchungen über Karzinomimmunität bei Mäusen. Münchener Medizinische Wochenschrift 51, 2517-2519 (1906). 4G. I. Abelev, S. D. P., N. I. Khramkova, Z. A. Postnikova and I. S. Irlin. Production of Embryonal α-Globulin by Transplantable Mouse Hepatomas. Transplantation 1, 174–180 (1963). 5IuS, T. Detection of embryo-specific alpha-globulin in the blood serum of a patient with primary liver cancer. Vopr Med Khim 10, 90-91 (1964). 6Cornejo, K., Shi, M. & Jiang, Z. Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma. Human pathology 43, 1567-1572 (2012). 7Yong, K. J. et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. The New England journal of medicine 368, 2266-2276, doi:10.1056/NEJMoa1300297 (2013). 8Capurro, M. et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125, 89-97 (2003). 9Ashworth, T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14, 146-149 (1869). 10Fidler, I. J. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. NATURE REVIEWS 3, 1-6 (2003). 11Christine, Chaffer, L. & Weinberg, R. A. A Perspective on Cancer Cell Metastasis. Science 331 (2011). 12Alix-Panabieres, C. & Pantel, K. Circulating tumor cells: liquid biopsy of cancer. Clinical chemistry 59, 110-118 (2013). 13Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001). 14Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976). 15Campbell, L. L. & Polyak, K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell cycle 6, 2332-2338 (2007). 16Visvader, J. E. & Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature reviews. Cancer 8, 755-768, doi:10.1038/nrc2499 (2008). 17Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer research 69, 1302-1313 (2009). 18Fang, D. et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer research 65, 9328-9337 (2005). 19Chiba, T. et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties. Hepatology 44, 240-251 (2006). 20Singh, A. & Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741-4751 (2010). 21Klonisch, T. et al. Cancer stem cell markers in common cancers - therapeutic implications. Trends in molecular medicine 14, 450-460 (2008). 22Baltimore, D. Report of the Ad Hoc Program Advisory Committee on Complex Genomes. Reston, VA, February (1988). 23Mark D. Adams, J. M. K., Jeannine D. Gocayne, Mark Dubnick, Mihael H., Polymeropoulos, H. X., Carl R. Merril, Andrew Wu, Bjorn Olde, Ruben F. Moreno, & Anthony R. Kerlavage, W. R. M., J. Craig Venter. Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project. Science 252, 1651-1656 (1991). 24Boguski, M. S., Lowe, T. M. j. & Tolstoshev, C. M. dbEST- database for expressed sequence tags. Nature genetics 4, 332-333 (1993). 25周靖恆. 結合生物資訊的方法探討腫瘤相關基因在人類腎臟癌中的表現. (2005). 26He, L.-Z. et al. A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin . Clinical Cancer Research 10, 1920-1927 (2004). 27Takashi Shimokawa et al. Involvement of the FGF18 Gene in Colorectal Carcinogenesis, as a Novel Downstream Target of the beta-CateninT-Cell Factor Complex. Cancer Research 63, 6116–6120 (2003). 28Hsu, C. et al. Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach. Oncogene 30, 654-667 (2011). 29陳怡文. 結合生物資訊暨實驗篩選以尋找 Wnt/β-catenin 傳遞路徑之新穎基因. (2011). 30Guo, Y. et al. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384, 51-61 (2006). 31Moss, E. G. & Tang, L. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Developmental Biology 258, 432-442 (2003). 32Cheng, S. W. et al. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma. PloS one 8, e80053, doi:10.1371/journal.pone.0080053 (2013). 33Zhou, J., Ng, S.-B. & Chng, W.-J. LIN28/LIN28B: An emerging oncogenic driver in cancer stem cells. The international journal of biochemistry & cell biology 45, 973-978, doi:10.1016/j.biocel.2013.02.006 (2013). 34Edwards, P. A. Fusion genes and chromosome translocations in the common epithelial cancers. The Journal of pathology 220, 244-254 (2010). 35Teixeira, M. R. Recurrent fusion oncogenes in carcinomas. Critical Reviews™ in Oncogenesis 12 (2006). 36Abe, A. et al. A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22). Cancer genetics 205, 608-611, doi:10.1016/j.cancergen.2012.10.001 (2012). 37Okuda, T., Nishimura, M., Nakao, M. & Fujitaa, Y. RUNX1/AML1: a central player in hematopoiesis. International journal of hematology 74, 252-257 (2001). 38Anderl, S., Konig, M., Attarbaschi, A. & Strehl, S. PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia. Molecular cytogenetics 8, 48 (2015). 39Cobaleda, C., Schebesta, A., Delogu, A. & Busslinger, M. Pax5: the guardian of B cell identity and function. Nature immunology 8, 463-470 (2007). 40Urbánek, P., Wang, Z.-Q., Fetka, I., Wagner, E. F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5BSAP. Cell 79, 901-912 (1994). 41Horton, P. et al. WoLF PSORT: protein localization predictor. Nucleic acids research 35, W585-587 (2007). 42Szklarczyk, D. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic acids research 43, D447-452 (2015). 43Yamashita, T. et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136, 1012-1024. e1014 (2009). 44Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007). 45Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nature medicine 10, 789-799 (2004). 46Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery 2, 401-404 (2012). 47Szklarczyk, D. et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic acids research 39, D561-D568 (2011).
|